Millennium Management’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,968
| Closed | -$204K | – | 4821 |
|
|
2023
Q1 | $204K | Sell |
4,968
-23,758
| -83% | -$976K | ﹤0.01% | 3849 |
|
|
2022
Q4 | $1.18M | Buy |
28,726
+15,080
| +111% | +$617K | ﹤0.01% | 3041 |
|
|
2022
Q3 | $548K | Buy |
13,646
+1,359
| +11% | +$54.6K | ﹤0.01% | 3779 |
|
|
2022
Q2 | $516K | Buy |
12,287
+5,059
| +70% | +$212K | ﹤0.01% | 3862 |
|
|
2022
Q1 | $327K | Buy |
+7,228
| New | +$327K | ﹤0.01% | 4359 |
|
|
2021
Q3 | – | Sell |
-11,712
| Closed | -$606K | – | 5524 |
|
|
2021
Q2 | $606K | Buy |
+11,712
| New | +$606K | ﹤0.01% | 4064 |
|
|
2017
Q4 | – | Sell |
-21,158
| Closed | -$900K | – | 3783 |
|
|
2017
Q3 | $900K | Buy |
+21,158
| New | +$900K | ﹤0.01% | 2344 |
|
|
2015
Q4 | – | Sell |
-4,958
| Closed | -$233K | – | 3533 |
|
|
2015
Q3 | $233K | Buy |
+4,958
| New | +$233K | ﹤0.01% | 2841 |
|
|
2015
Q2 | – | Sell |
-29,134
| Closed | -$1.8M | – | 3450 |
|
|
2015
Q1 | $1.8M | Buy |
29,134
+19,482
| +202% | +$1.2M | ﹤0.01% | 1851 |
|
|
2014
Q4 | $521K | Buy |
+9,652
| New | +$521K | ﹤0.01% | 2520 |
|